An observational study in Peripheral Artery Disease, sponsored by University Hospital, Angers. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-07-17.
Sponsored by University Hospital, Angers · Observational
The purpose of this study is to test the routine faisibility of a questionnaire to estimate walking impairment(The WELCH questionnaire) in patients investigated for suspected PAD.
The WELCH and WIQ questionnaires are self completed by the patients and scored by the physician after self-completion.
1,573 studies on the registry are indexed under Peripheral Arterial Disease; 284 are open to participants now.
This study's enrollment of 150 is below the median of 190 across 427 observational studies indexed under Peripheral Arterial Disease.
Browse Peripheral Arterial Disease studies →University Hospital, Angers is the lead sponsor of 477 studies on the registry; 119 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients referred for arterial leower limb investigations
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients referred for investigation of assumed peripheral artery disease (PAD)
Scoring of the WELCH. Percent scored questionnaires
Predetermined scored . Scoring is optional and compared to scoring of the WIQ
Time frame: 1 day
The record gives a start of Jul 2012, a primary completion of Jul 2014 and a completion of Jul 2014. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.